Epilepsy research, 1992-03, Vol.11 (1), p.67-70
1992
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Hyponatremic coma under oxcarbazepine therapy
- Ist Teil von
- Epilepsy research, 1992-03, Vol.11 (1), p.67-70
- Ort / Verlag
- Amsterdam: Elsevier B.V
- Erscheinungsjahr
- 1992
- Quelle
- Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
- Beschreibungen/Notizen
- Oxcarbazepine (OXC) is considered to be a promising new antiepileptic drug with similar efficacy and better tolerability compared to carbamazepine (CBZ). However, hyponatremia is supposed to occur even more often than with CBZ. We report on a patient who developed hyponatremic coma under OXC with a serum sodium level of 115 mmol/1, the second published case of OXC-induced hyponatremia with serious clinical adverse effects.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0920-1211eISSN: 1872-6844DOI: 10.1016/0920-1211(92)90023-MTitel-ID: cdi_crossref_primary_10_1016_0920_1211_92_90023_M
- Format
- –
- Schlagworte
- Anticonvulsants - adverse effects, Anticonvulsants - therapeutic use, Biological and medical sciences, Carbamazepine - adverse effects, Carbamazepine - analogs & derivatives, Carbamazepine - therapeutic use, Coma - chemically induced, Drug toxicity and drugs side effects treatment, Epilepsy - drug therapy, Female, Humans, Hyponatremia - chemically induced, Hyponatremic coma, Medical sciences, Middle Aged, Oxcarbazepine, Pharmacology. Drug treatments, Toxicity: nervous system and muscle